Literature DB >> 9261840

Thiamine deficiency alters APP but not presenilin-1 immunoreactivity in vulnerable brain regions.

N Y Calingasan1, S E Gandy, G E Gibson.   

Abstract

Presenilin-1 (PS-1) and amyloid precursor protein (APP) have been linked to the pathogenesis of Alzheimer's disease. While APP accumulation is well documented in several models of brain injury, the role of PS-1 levels in neurodegeneration, if any, remains to be elucidated. The current studies examined PS-1 and APP expression in brain following thiamine deficiency (TD), a nutritional model associated with impaired oxidation and selective neurodegeneration. TD did not alter PS-1 immunoreactivity in any region of rodent brain before or after cell loss. In contrast, APP immunoreactivity accumulated in swollen neurites within, or around lesions in rats, or in abnormal clusters in mice. Thus, alterations in APP but not PS-1 levels are involved in TD-induced neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9261840     DOI: 10.1097/00001756-199707280-00041

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  3 in total

1.  Thiamine deficiency induces oxidative stress and exacerbates the plaque pathology in Alzheimer's mouse model.

Authors:  Saravanan S Karuppagounder; Hui Xu; Qingli Shi; Lian H Chen; Steve Pedrini; David Pechman; Harriet Baker; M Flint Beal; Sam E Gandy; Gary E Gibson
Journal:  Neurobiol Aging       Date:  2008-04-10       Impact factor: 4.673

2.  Vitamin B1 (thiamine) uptake by human retinal pigment epithelial (ARPE-19) cells: mechanism and regulation.

Authors:  Veedamali S Subramanian; Zainab M Mohammed; Andres Molina; Jonathan S Marchant; Nosratola D Vaziri; Hamid M Said
Journal:  J Physiol       Date:  2007-04-26       Impact factor: 5.182

3.  Translocation of amyloid precursor protein C-terminal fragment(s) to the nucleus precedes neuronal death due to thiamine deficiency-induced mild impairment of oxidative metabolism.

Authors:  Saravanan S Karuppagounder; Hui Xu; David Pechman; Lian H Chen; Lorraine A DeGiorgio; Gary E Gibson
Journal:  Neurochem Res       Date:  2008-03-04       Impact factor: 3.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.